Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy

Neurosurgery Clinics of North America
Isaac YangAndrew T Parsa

Abstract

Recent advancements have made radiation and chemotherapy the standard of care for newly diagnosed glioblastomas. The use of these therapies has resulted in an increased diagnosis of pseudoprogression and radiation-induced necrosis. Standard MRI techniques are inadequate in differentiating tumor recurrence from posttreatment effects. Diagnosis of a posttreatment lesion as glioma recurrence rather than radiochemotherapy or immunotherapy treatment effect is critical. This increase in accuracy plays a role as newer immunotherapies incurring posttreatment effects on MRI emerge. Advancements with magnetic resonance spectroscopy, diffusion-weighted imaging, and functional positron emission tomography scans have shown promising capabilities. Further investigations are necessary to assess the imaging algorithms and accuracy of these modalities to differentiate true glioma recurrence from radiotherapy or immunotherapy treatment effect.

References

Jan 1, 1991·Medical and Pediatric Oncology·M GriebelB Hockenberger
Jan 1, 1985·Journal of Neuro-oncology·R SoffiettiD Schiffer
Sep 1, 1996·International Journal of Radiation Oncology, Biology, Physics·G S BaumanD A Larson
Apr 5, 2001·European Journal of Radiology·R LuypaertM Osteaux
Apr 6, 2001·Seminars in Surgical Oncology·K K HerfarthJ Debus
Jul 20, 2002·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Suresh K MukherjiMauricio Castillo
Feb 22, 2003·European Journal of Radiology·Roland Bammer
Apr 12, 2003·Neuroimaging Clinics of North America·Terence Z WongR Edward Coleman
Jul 17, 2003·The Neurologist·Pierre Giglio, Mark R Gilbert
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Nathan S FloydE Brian Butler
Apr 28, 2005·Expert Review of Neurotherapeutics·Carsten NiederMichael Molls
Sep 6, 2005·Neuroradiology·Matthias Philipp LichyHeinz-Peter Schlemmer
Nov 24, 2005·AJR. American Journal of Roentgenology·Patrick WeybrightLarry Junck
Feb 8, 2006·Acta Neuropathologica·Arie Perry, Robert E Schmidt
Mar 7, 2006·International Journal of Radiation Oncology, Biology, Physics·Jeremy D RubenPasqual Fedele
Jun 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·René-Olivier MirimanoffRoger Stupp
Feb 10, 2007·International Journal of Radiation Oncology, Biology, Physics·Qing-Shi ZengDe-Chao Feng
Nov 27, 2007·International Journal of Radiation Oncology, Biology, Physics·Ramona Mayer, Peter Sminia
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani

❮ Previous
Next ❯

Citations

May 14, 2011·Journal of Neuro-oncology·Emilie A Steffen-SmithKatherine E Warren
May 15, 2013·Journal of Neuro-oncology·Graeme F WoodworthPeter C Burger
Oct 16, 2010·Journal of Translational Medicine·Michelle J HickeyCarol A Kruse
Jun 2, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bálint AlkonyiCsaba Juhász
Jul 10, 2014·BioMed Research International·Emilie A Steffen-SmithKatherine E Warren
May 23, 2012·Expert Opinion on Drug Delivery·Yu Liu, Weiyue Lu
Mar 24, 2012·Neurosurgery Clinics of North America·Arman Jahangiri, Manish K Aghi
Jul 26, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·P SangheraI R Whittle
Sep 12, 2015·The International Journal of Biochemistry & Cell Biology·Marina P GehringFernanda B Morrone
Apr 3, 2014·International Journal of Cancer. Journal International Du Cancer·Maxim A ShevtsovBoris A Margulis
Mar 27, 2012·International Journal of Radiation Oncology, Biology, Physics·Emilie A Steffen-SmithKatherine E Warren
Nov 21, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Norbert GalldiksKarl-Josef Langen
Oct 16, 2016·Magnetic Resonance Imaging Clinics of North America·Raymond Y Huang, Patrick Y Wen
May 1, 2020·NMR in Biomedicine·Andrew A MaudsleyBrian J Soher
Mar 8, 2018·Therapeutic Advances in Neurological Disorders·Hari NanduRaymond Y Huang
May 5, 2011·Expert Review of Neurotherapeutics·Hideho Okada, Ian F Pollack
Sep 2, 2017·Expert Review of Neurotherapeutics·Norbert GalldiksKarl-Josef Langen
May 1, 2018·Journal of Magnetic Resonance·Joel R GarbowScott C Beeman
Jun 1, 2021·Neuro-oncology Practice·Na Tosha N GatsonRajiv Panikkar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.